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Items for this week’s EPI Update include: 
• Hepatitis A prevention and control  
• Iowa Disease Surveillance System update  
• World Breastfeeding Week August 1-7,2007  
• Caffeine in breast milk  
  
Hepatitis A prevention and control 
Recently there has been a cluster of hepatitis A cases in Central Iowa, and 
CADE is using this opportunity to educate providers regarding hepatitis A 
prevention and control. 
Hepatitis A is a vaccine-preventable disease and vaccination is recommended for 
the following:  
  
• All children 12-23 months of age  
• International travelers to high or intermediate risk countries  
• Men who have sex with men  
• Persons who use illegal drugs  
• Persons with chronic liver disease  
• Persons with occupational risk  
• Persons with clotting factor disorders  
  
Children 1-18 years of age should receive a single primary dose of the pediatric 
formulation followed by a booster dose 6-12 months later. Adults 19 years of age 
and older should receive one dose of the adult formulation followed by a booster 
6-12 months later. 
  
Protection might not be complete until four weeks after vaccination, for optimal 
protection, persons traveling to high risk countries less than four weeks after the 
initial dose should also receive immune globulin (IG) (0.02 ml/kg) at a different 
anatomic injection site.  
  
When administered intramuscularly before exposure to hepatitis A virus, or within 
two weeks after exposure, IG is 80 percent to 90 percent effective in preventing 
hepatitis A disease. A single intramuscular dose of 0.02 ml/kg of IG confers 
protection for less than three months; 0.06 ml/kg protects for three to five 
months. 
  
IG should be given to exposed persons who have not previously received 
hepatitis A vaccine as soon as possible, but not more than two weeks after the 
exposure. Recipients may include persons who had close contact (household or 
sexual) with a person who has hepatitis A disease; staff and attendees at child 
care centers where a hepatitis A case has been recognized; and persons in 
certain common-source exposure situations (e.g., patrons of a food 
establishment with an HAV-infected food handler, if the risk of transmission is 
determined to be high). Persons who have received one dose of hepatitis A 
vaccine at least one month before an HAV exposure do not need IG. 
  
IG can interfere with the response to live injected vaccines (e.g., measles, 
mumps, rubella (MMR), and varicella vaccines). Live vaccines that were given 
less than two weeks before IG administration can be affected; immunization 
records should be checked for dates of MMR and varicella administration. Live 
vaccines that were administered less than two weeks prior to receipt of IG should 
be re-administered. Administration of live vaccines should be delayed for at least 
three months after administration of IG. 
  
Iowa Disease Surveillance System update 
The Iowa Disease Surveillance System (IDSS) is a newly developed system that 
is intended to streamline and enhance communication and collaboration among 
laboratory, hospital, and public health (local and state) personnel related to 
infectious disease reporting and surveillance throughout Iowa.  
  
The statewide training sessions scheduled for July and August of 2007 are 
winding down. Those attending a training session have been able to use a 
training version of the application. This is an earlier version of IDSS than the one 
that will be installed in a few weeks. The training version communicates via the 
Internet and interfaces with a central database incorporating the complex security 
features that will be present in the final production version. 
  
Despite some setup issues specific to various training locations, overall feedback 
about IDSS has been positive. Much that has been learned will be useful for 
statewide implementation at hospitals and local public health agencies. Local 
IDSS users at hospitals and local public health agencies will receive notification 
when IDSS is available for installation. 
  
Those hospitals and local public health agencies that participated in the pilot 
continue to use IDSS exclusively for disease reporting to CADE. 
  
World Breastfeeding Week (August 1-7)  
World Breastfeeding Week (WBW) is from August 1 through August 7. The 
theme for this year is the “Power of One”. For information about WBW activities 
and the many benefits of breastfeeding (including protection against infectious 
disease), visit the La Leche League website at www.lllusa.org/wbw/.  
  
Caffeine in breast milk 
Excessive caffeine can cause poor eating, sleeping, and jitters in infants. 
Caffeine is excreted in breast milk and a nursing mother should be aware of how 
much caffeine she can safely consume. Studies show that drinking two or fewer 
cups of coffee a day while nursing should not adversely affect infants. Two cups 
of plain, brewed coffee contains approximately 270mg of caffeine. The following 
is a list of beverages and their estimated caffeine content: 
  
• 1 oz shot of espresso=30-50mg  
• 1 8oz cup of instant coffee=90mg  
• 1 Starbucks’ Coffee Grande (16oz)=259mg  
• 1 8oz cup of black tea=40-70mg  
• 1 can of Mountain Dew=55mg  
• 1 8.5oz can of Red Bull=80mg  
  
Caffeine elimination in infants is much slower because of immature renal and/or 
hepatic function. An infant younger than six months will eliminate approximately 
half of any caffeine consumed three to four days after consumption. About 86 
percent of caffeine will be eliminated after six days. By nine months most infants 
are able to rid their bodies of caffeine as efficiently as an adult.  Nursing mothers 
should avoid more than two cups of coffee per day or the equivalent amount of 
caffeine.  
  
For more information on the content of caffeine in beverages, visit 
www.mayoclinic.com/health/caffeine/AN01211. 
  
Have a healthy and happy week! 
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